OsteoporosisBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.6999.263 (Published 22 July 1995) Cite this as: BMJ 1995;311:263
- M Azria
- Head of calcitonin biology and safety Research and Development Division, Sandoz Pharmaceuticals, 4002 Basle, Switzerland
EDITOR,--In their article on osteoporosis Nicola Peel and Richard Eastell state that “a nasal preparation [of calcitonin] …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial